Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TARS
TARS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TARS News
Trinity Industries Sees Surge in Options Trading Volume
1d ago
NASDAQ.COM
Tarsus Pharmaceuticals Shares Surge 7.5% on Strong Sales Growth
5d ago
NASDAQ.COM
Tarsus Accused of Market Manipulation by Culper Research
6d ago
stocktwits
Tarsus Pharmaceuticals Shares Drop Amid Short Report
6d ago
seekingalpha
Live Nation and Riot Platforms See Active Options Trading
Jun 26 2026
NASDAQ.COM
Achieve Life Sciences Appoints New Board Members Ahead of Cytisinicline Launch
Jun 02 2026
Globenewswire
Tarsus Pharmaceuticals to Participate in Upcoming Investor Conferences
May 28 2026
Newsfilter
John Cena Partners with Tarsus to Raise Awareness of Eyelid Disease
May 14 2026
Newsfilter
Tarsus Pharmaceuticals Q1 2026 Earnings Call Highlights
May 07 2026
seekingalpha
Tarsus (TARS) Q1 2026 Earnings Transcript
May 06 2026
NASDAQ.COM
Tarsus Pharmaceuticals Q1 Earnings Announcement Scheduled
May 05 2026
seekingalpha
Tarsus Pharmaceuticals to Report Q1 2026 Financial Results on May 6
Apr 29 2026
Newsfilter
Tarsus Initiates Clinical Trial for Lyme Disease Prevention
Mar 31 2026
Newsfilter
Tarsus Pharmaceuticals Executive Sells Shares Amid Strong Sales Growth
Mar 24 2026
Fool
Tarsus Pharmaceuticals Executive Sells Shares for Tax Obligations
Mar 24 2026
NASDAQ.COM
TARSUS PHARMACEUTICALS INC - QUALIFIED FOR EXTRA MILESTONES AND GRADUATED ROYALTIES FOR TP-03 IN GREATER CHINA
Mar 23 2026
moomoo
Show More News
